AC
Armistice Capital Portfolio holdings
AUM
$2.64B
1-Year Return
0.99%
This Quarter Return
+22.05%
1 Year Return
+0.99%
3 Year Return
+16.29%
5 Year Return
+18.04%
10 Year Return
+34.8%
AUM
$1.9B
AUM Growth
+$537M
(+39%)
Cap. Flow
+$44.9M
Cap. Flow
% of AUM
2.37%
Top 10 Holdings %
Top 10 Hldgs %
30.44%
Holding
97
New
19
Increased
29
Reduced
22
Closed
18
Top Buys
| 1 |
Medtronic
MDT
|
$54.3M |
| 2 |
Biogen
BIIB
|
$42.3M |
| 3 |
UnitedHealth
UNH
|
$33M |
| 4 |
Lantheus
LNTH
|
$32.9M |
| 5 |
AutoZone
AZO
|
$31.6M |
Top Sells
| 1 |
VXRT
Vaxart
VXRT
|
$222M |
| 2 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$40.6M |
| 3 |
Deckers Outdoor
DECK
|
$30.5M |
| 4 |
Amazon
AMZN
|
$29M |
| 5 |
Dollar Tree
DLTR
|
$22.4M |
Sector Composition
| 1 | Healthcare | 54.5% |
| 2 | Consumer Discretionary | 18.97% |
| 3 | Consumer Staples | 11.9% |
| 4 | Technology | 6.34% |
| 5 | Industrials | 4.03% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
AIMT
51
DELISTED
Aimmune Therapeutics, Inc.
AIMT
| $15.4M | 0.68% |
924,000
+324,000
| +54% | +$5.41M |
|
52
argenx
ARGX
$45.9B
| $15.3M | 0.67% |
+68,000
| New | +$15.3M |
|
53
Kohl's
KSS
$1.86B
| $15.3M | 0.67% |
+735,302
| New | +$15.3M |
|
54
Assembly Biosciences
ASMB
$183M
| $13.9M | 0.61% |
49,667
-10,666
| -18% | -$2.98M |
|
55
CRISPR Therapeutics
CRSP
$4.99B
| $13.8M | 0.61% |
188,000
-48,000
| -20% | -$3.53M |
|
|
EGRX
56
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
| $13.5M | 0.59% |
+282,000
| New | +$13.5M |
|
57
CVS Health
CVS
$93.6B
| $11.2M | 0.49% |
172,000
-206,000
| -54% | -$13.4M |
|
|
CLVS
58
DELISTED
Clovis Oncology, Inc.
CLVS
| $10.8M | 0.47% |
+1,600,000
| New | +$10.8M |
|
59
Jack in the Box
JACK
$386M
| $10.1M | 0.44% |
+135,703
| New | +$10.1M |
|
60
Elastic
ESTC
$9.21B
| $9.22M | 0.4% |
+100,000
| New | +$9.22M |
|
|
ZEN
61
DELISTED
ZENDESK INC
ZEN
| $8.85M | 0.39% |
100,000
+42,000
| +72% | +$3.72M |
|
62
Kiora Pharmaceuticals
KPRX
$9.2M
| $8.73M | 0.38% |
5,043
| – | – |
|
63
Thermo Fisher Scientific
TMO
$186B
| $8.7M | 0.38% |
24,000
-4,000
| -14% | -$1.45M |
|
|
ADMS
64
DELISTED
Adamas Pharmaceuticals, Inc.
ADMS
| $7.02M | 0.31% |
2,742,000
| – | – |
|
65
Booking.com
BKNG
$178B
| $6.37M | 0.28% |
+4,000
| New | +$6.37M |
|
|
TTPH
66
DELISTED
Tetraphase Pharmaceuticals, Inc.
TTPH
| $3.58M | 0.16% |
1,419,507
| – | – |
|
|
ONCT
67
DELISTED
Oncternal Therapeutics, Inc. Common Stock
ONCT
| $3.57M | 0.16% |
+62,836
| New | +$3.57M |
|
68
Carter's
CRI
$1.05B
| $3.41M | 0.15% |
42,201
-172,799
| -80% | -$13.9M |
|
|
TMDI
69
DELISTED
Titan Medical Inc. Ordinary Shares
TMDI
| $1.97M | 0.09% |
+2,363,457
| New | +$1.97M |
|
70
Iterum Therapeutics
ITRM
$30.3M
| $1.5M | 0.07% |
+84,170
| New | +$1.5M |
|
|
VXRT
71
DELISTED
Vaxart
VXRT
| $1.29M | 0.06% |
145,523
-25,054,477
| -99% | -$222M |
|
72
Yatra Online
YTRA
$88.7M
| $1.22M | 0.05% |
+1,800,000
| New | +$1.22M |
|
73
Minerva Neurosciences
NERV
$16.4M
| $1.08M | 0.05% |
37,500
| – | – |
|
|
XYLO
74
DELISTED
Xylo Technologies
XYLO
| $962K | 0.04% |
32,143
| – | – |
|
75
Rigel Pharmaceuticals
RIGL
$742M
| $957K | 0.04% |
+52,270
| New | +$957K |
|